Long-Term Survival of Implantable Cardioverter Defibrillator Recipients with End-Stage Renal Disease

Conclusion ESRD patients are at significantly increased risk of mortality as compared with a non-dialysis cohort. While the majority of these patients survive more than one year post-diagnosis, the three-year mortality is high (43%). Randomized studies addressing the benefits of ICDs in ESRD patients are needed to better define their value for primary prevention of SCD.
Source: Journal of Arrhythmia - Category: Cardiology Source Type: research